Trademark Overview
On Friday, September 2, 2022, a trademark application was filed for CHEMILOGIX with the United States Patent and Trademark Office. The USPTO has given the CHEMILOGIX trademark a serial number of 97576997. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 5, 2023. This trademark is owned by Empress Therapeutics, Inc.. The CHEMILOGIX trademark is filed in the Pharmaceutical Products category with the following description:
Small drug molecules; small molecules; small molecules that are encoded in DNA related to human health and disease; biological and chemical agents for scientific and research use; chemical compounds; pharmaceutical preparations and therapeutics for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; drug development; drug development software platform featuring artificial intelligence and machine learning; software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, rese...
